Page last updated: 2024-11-07

penicillamine and Bone Diseases, Metabolic

penicillamine has been researched along with Bone Diseases, Metabolic in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research Excerpts

ExcerptRelevanceReference
"The prevalence of osteopenia and osteoporosis in children with WD was found as 22."1.35Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy. ( Doneray, H; Ertekin, V; Selimoglu, MA; Yildirim, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Selimoglu, MA1
Ertekin, V1
Doneray, H1
Yildirim, M1

Other Studies

1 other study available for penicillamine and Bone Diseases, Metabolic

ArticleYear
Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
    Journal of clinical gastroenterology, 2008, Volume: 42, Issue:2

    Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Chelating Agents; Child; Child, Preschool; Femal

2008